Jubilant Pharmova Ltd 2006 SR
The report highlights Jubilant Organosys's sustainability performance for fiscal year 2006, focusing on its triple bottom line approach. Key achievements include a 28.6% increase in net sales and significant progress in environmental initiatives, such as reclaiming 30 acres of old lagoons at the Nira plant to solve odour issues. The company reported zero fatal accidents and a reduction in accident rates through international safety capacity building. Notably, its Gajraula medical centre was recognized as a WHO DOTS centre for TB treatment. The report follows GRI 2002 guidelines and includes external assurance by Ernst & Young.
Company: Jubilant Pharmova Ltd
Sector: Manufacturing
Country: India
Year: 2006
Type: SR
Pages: 50
Back to company
Jubilant Pharmova Ltd
Corporate Sustainability Report
The report highlights Jubilant Organosys's sustainability performance for fiscal year 2006, focusing on its triple bottom line approach. Key achievements include a 28.6% increase in net sales and significant progress in environmental initiatives, such as reclaiming 30 acres of old lagoons at the Nira plant to solve odour issues. The company reported zero fatal accidents and a reduction in accident rates through international safety capacity building. Notably, its Gajraula medical centre was recognized as a WHO DOTS centre for TB treatment. The report follows GRI 2002 guidelines and includes external assurance by Ernst & Young.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2006
Reporting Period
Apr 1, 2005 - Mar 31, 2006
Fiscal Year
2006
Published
Aug 11, 2006
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Workplace Fatalities
Employees